Clinical trial: Ongoing research and development of epilepsy treatments will likely accelerate industry growth
Companies in this industry are engaged in manufacturing medications to control epilepsy, which is a neurological disorder characterized by seizures. Epilepsy drugs are commonly known as anticonvulsants or antiepileptic medications (AEM).
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Glaxosmithkline Plc
- Ucb S.A.
- Johnson & Johnson
- Pfizer Inc.
- Novartis International Ag
Methodology
LOADING...